Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Safety is a key concern for investors. Learn which option, index funds or individual stocks, offers better security for your investments.
24,450 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
NVIDIA has stunned investors with a dramatic dividend move and a massive buyback. This article breaks down what it me...
A $150,000 dividend income stream can look generous, but the IRS taxes it differently depending on how the income is ...
The retirement myth of needing a million dollars is fading. Income-focused strategies and Social Security can cover a...
Anthropic has filed a high-stakes lawsuit against the U.S. Department of War over DoD procurement actions, threatenin...
A two-sleeve retirement strategy blends a protective buffered market sleeve with a high-yield income sleeve to provid...
Intel faces renewed pressure as AMD gains share in the server CPU market, driven by AI workloads. This guide explains...
Micron has surged into a market-defining position as traders weigh earnings potential against memory-price risk. Anal...
Oil shipments remain in flux at the Strait of Hormuz as a pressure-packed crisis persists. The shadow fleet illegal s...
A narrow, theme-driven ETF focused on generative AI shows mixed results as broader AI funds rally. The concentrated a...
Retirees face a stubborn reality: utility bills keep arriving. A disciplined mix of dividend growth stocks, inflation...
In mid-2026, the Amplify CWP Enhanced Dividend Income ETF climbs past $5.25 billion in assets as its monthly distribu...